Charles Schwab Investment Management Inc Cullinan Oncology, Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 370,631 shares of CGEM stock, worth $6.37 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
370,631
Previous 257,873
43.73%
Holding current value
$6.37 Million
Previous $4.39 Million
47.09%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CGEM
# of Institutions
140Shares Held
65.9MCall Options Held
77.2KPut Options Held
15.9K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$131 Million21.42% of portfolio
-
Bvf Inc San Francisco, CA5.75MShares$98.9 Million3.07% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$61 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$58.7 Million15.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.28MShares$56.4 Million1.2% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $784M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...